SCHEMBL5729319

SCHEMBL5729319

NCCCCN1CCC(n2nnc3ccccc32)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.53
HTR7 P34969 1/20 0.53
USP2 O75604 5/20 0.53
GAA P10253 1/20 0.53
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
BAP1 Q92560 1/20 0.46
CHRM4 P08173 1/20 0.45
SCD O00767 1/20 0.45
P2RX7 Q99572 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5729603 0.82 HTR7 (0.62) HTR2AHTR7USP2GAACYP3A4
SCHEMBL17538382 0.80 CYP3A4 (0.58) HTR2AHTR7USP2GAACYP3A4
SCHEMBL5857440 0.79 CYP2D6 (0.61) HTR2AHTR7USP2GAACYP3A4
SCHEMBL11201625 0.78 USP2 (0.58) HTR2AHTR7USP2GAACYP3A4
SCHEMBL11100678 0.77 ALDH1A1 (0.73) USP2GAACYP3A4CYP2D6CYP2C19
SCHEMBL904850 0.77 USP2 (0.60) HTR2AHTR7USP2GAACYP3A4
SCHEMBL5633033 0.77 USP2 (0.58) HTR2AHTR7USP2GAACYP3A4
SCHEMBL904833 0.76 CCR3 (0.57) HTR2AHTR7USP2GAA
SCHEMBL5857451 0.76 CYP2D6 (0.52) HTR2AHTR7USP2GAACYP3A4
Lithium Ion SCHEMBL5633232 0.75 USP2 (0.57) HTR2AHTR7USP2GAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1044197-B1 PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKYNE CARBOXAMIDES AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSANTS ASTELLAS PHARMA GMBH (DE) 2006-04-19 EP disclosed
US-6593344-B1 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases KLINGE PHARMA GMBH (DE) 2003-07-15 US disclosed
EP-1044197-A2 NEW PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES Klinge Pharma GmbH (DE) 2000-10-18 EP disclosed
WO-1999031060-A2 PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES AS CYTOSTATICS AND IMMUNESUPPRESSANTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO disclosed